• 点赞
  • 评论
  • 收藏

BRIEF-Emergent Biosolutions Says Issued A Statement On Status Of Response To FDA's Observations Related To Company's Baltimore Bayview Facility

Reuters2021-05-12

May 12 (Reuters) - Emergent BioSolutions Inc :

* EMERGENT BIOSOLUTIONS - ISSUED A STATEMENT ON STATUS OF RESPONSE TO FDA'S OBSERVATIONS RELATED TO COMPANY'S BALTIMORE BAYVIEW FACILITY

* EMERGENT BIOSOLUTIONS - CONTINUE TO HAVE ON-GOING DIALOGUE WITH FDA & JOHNSON & JOHNSON AS WE WORK TO RELEASE DRUG SUBSTANCE, RESUME PRODUCTION

* EMERGENT BIOSOLUTIONS - HAVE ALREADY STARTED MAKING IMPROVEMENTS, CO FULLY COMMITTED TO MAKING NECESSARY ENHANCEMENTS TO MEET/EXCEED FDA'S STANDARDS

Source: [ Further company coverage:

((reuters.briefs@thomsonreuters.com;))

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论

empty
暂无评论
 
 
 
 

热议股票

 
 
 
 
 

7x24